Breaking

Harris admits silence on Biden’s 2024 re-election bid was ‘recklessness’
Ramaswamy endorses Winsome Earle-Sears for Virginia governor, rally planned next week in swing suburb
‘So many lies’: Schumer ambushes GOP with surprise Epstein files amendment
Two Republicans join Dems to save Schumer’s surprise push to force release of Epstein files
Charlie Kirk’s assassination latest case of conservatives being targeted for murder
Dozens of Democrats mutiny must-pass defense bill over GOP priorities
Charlie Kirk assassination sparks bipartisan uproar over political violence as Utah manhunt underway
Self-representation ‘almost always a mistake,’ expert warns as Trump trial begins

Politics
World
Investing
Business
Search for:

Investing

First patient dosed in Phase IIb imaging for Brain Mets

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

Battery Anode Material Refinery – Design & Location Update

September 11, 2025

Shell Contract Consolidates Top Tier Global Energy Position

September 11, 2025

Corporate Presentation

September 11, 2025

Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!

Your name
Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Categories
- Business (1,469)
- Investing (3,806)
- Politics (4,959)
- World (4,369)

Disclaimer: FinancesDataDriven.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest Posts

Copyright © 2025 financesdatadriven.com | All Rights Reserved

Top

Politics
World
Investing
Business

Type above and press Enter to search. Press Esc to cancel.